Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL770171 | 0.98 | ELANE (0.54) | ELANEABCB1AKR1C3MAPTMAPK1 | |
| SCHEMBL31602130 | 0.98 | ELANE (0.54) | ELANEABCB1AKR1C3MAPTMAPK1 | |
| SCHEMBL2299380 | 0.96 | ELANE (0.53) | ELANEABCB1AKR1C3MAPTMAPK1 | |
| Sulfuric Acid SCHEMBL18204474 | 0.94 | ELANE (0.48) | ELANEABCB1AKR1C3MAPTMAPK1 | |
| SCHEMBL18204475 | 0.85 | ELANE (0.43) | ELANEABCB1AKR1C3MAPTMAPK1 | |
| SCHEMBL2228864 | 0.84 | ELANE (0.55) | ELANEABCB1AKR1C3MAPTMAPK1 | |
| SCHEMBL5073351 | 0.82 | MAPT (0.54) | ELANEABCB1AKR1C3MAPTMAPK1 | |
| SCHEMBL27694472 | 0.82 | IRAK4 (0.64) | ELANEABCB1AKR1C3MAPTMAPK1 | |
| SCHEMBL30668163 | 0.82 | MAPT (0.54) | ELANEABCB1AKR1C3MAPTMAPK1 | |
| Acetic Acid SCHEMBL21549818 | 0.81 | ELANE (0.53) | ELANEABCB1AKR1C3MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110244-A1 | NOVEL COMPOUND AND USE THEREOF | オリザ油化株式会社 | 2025-05-30 | — | — | WO | disclosed |
| CN-119968195-A | Aqueous polymer emulsion for cosmetics, method for producing same, and cosmetics | 东亚合成株式会社 | 2025-05-09 | — | — | CN | disclosed |
| US-20250082592-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION, ALLEVIATION OR TREATMENT OF SARCOPENIA, CONTAINING ROR-alpha ACTIVATOR JC1-40 | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-03-13 | — | — | US | disclosed |
| US-12221495-B2 | Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide | IGISU CO., LTD. (JP) | 2025-02-11 | — | — | US | disclosed |
| WO-2024232390-A1 | IRRITATION RELIEVING AGENT, PRODUCTION METHOD THEREOF AND SKIN EXTERNAL PREPARATION | リファインホールディングス株式会社 | 2024-11-14 | — | — | WO | disclosed |
| US-20240358779-A1 | EXTRACELLULAR VESICLES DERIVED FROM LACTOBACILLUS BACTERIA, AND USE THEREOF | MD HEALTHCARE INC. (KR) | 2024-10-31 | — | — | US | disclosed |
| WO-2024196194-A1 | NOVEL ENTEROCOCCUS FAECALIS HL1 STRAIN AND USE THEREOF | 재단법인 아산사회복지재단 | 2024-09-26 | — | — | WO | disclosed |
| CN-113924357-B | Bifidobacterium longum strain or cosmetic composition comprising cell lysate of said strain | 株式会社爱托健 | 2024-09-24 | — | — | CN | disclosed |
| WO-2024181594-A1 | BROCCOLI SPROUT FERMENTATION METHOD TO INCREASE ACTIVE INGREDIENT CONTENT, AND BROCCOLI SPROUT POWDER PRODUCED THEREBY | 주식회사 컴투네이처 | 2024-09-06 | — | — | WO | disclosed |
| US-12065512-B2 | Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide | IGISU CO., LTD. (JP) | 2024-08-20 | — | — | US | disclosed |
| US-20100286093-A1 | ANTI-INFLAMMATORY COMPOSITION CONTAINING DOCOSAHEXAENOYL LYSOPHOSPHATIDYLAMINE AS AN ACTIVE INGREDIENT | THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) | 2010-11-11 | — | — | US | disclosed |
| US-20100280231-A1 | WHITENING AGENT COMPRISING EQUOL OR ITS SACCHARIDE DERIVATIVE AS AN EFFECTIVE INGREDIENT | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2010-11-04 | — | — | US | disclosed |
| EP-2145615-A1 | SKIN-LIGHTENING AGENT CONTAINING EQUOL COMPOUND AS ACTIVE INGREDIENT | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2010-01-20 | — | — | EP | disclosed |
| US-20070231403-A1 | Natural composite preservatives | BIOSPECTRUM, INC. (KR) | 2007-10-04 | — | — | US | disclosed |
| EP-0887070-B1 | External composition for skin comprising sphingoglycolipid | KIBUN FOOD CHEMIFA (JP) | 2004-12-22 | — | — | EP | disclosed |
| US-6514744-B2 | Skin moisturizer | KIBUN FOOD CHEMIFA CO., LTD. (JP) | 2003-02-04 | — | — | US | disclosed |
| US-20020164351-A1 | External compositions for skin comprising sphingoglycolipid | KIBUN FOOD CHEMIFA CO., LTD. (JP) | 2002-11-07 | — | — | US | disclosed |
| US-6348201-B2 | SPHINGOGLYCOLIPID AVAILABLE AS COSMETIC AND MEDICINE, HAS POTENT MOISTURIZING EFFEACT AND PREVENTIVE EFFECT AGAINST SKIN ROUGHNESS; SPHINOGGLYCOLIPID CONTAINING SUGAR MOITIES AND AMIDE GROUP | KIBUN FOOD CHEMIFA CO., LTD. (JP) | 2002-02-19 | — | — | US | disclosed |
| US-20020006414-A1 | EXTERNAL COMPOSITION FOR SKIN COMPRISING SPHINGOGLYCOLIPID | FOODCHEMIFA CO., LTD. (JP) | 2002-01-17 | — | — | US | disclosed |
| EP-0887070-A1 | External composition for skin comprising sphingoglycolipid | Kibun Food ChemiFA Co., Ltd. (JP) | 1998-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286093-A1 | ANTI-INFLAMMATORY COMPOSITION CONTAINING DOCOSAHEXAENOYL LYSOPHOSPHATIDYLAMINE AS AN ACTIVE INGREDIENT | ALOX5, PLA2G4A, PLA2G10 | ELANE 123/4885ABCB1 4642/4885AKR1C3 1436/4885 |
| US-20250082592-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION, ALLEVIATION OR TREATMENT OF SARCOPENIA, CONTAINING ROR-alpha ACTIVATOR JC1-40 | TFAM, RORA, CKMT1A; CKMT1B | ELANE 4352/4885ABCB1 2190/4885AKR1C3 2163/4885 |
| US-20020164351-A1 | External compositions for skin comprising sphingoglycolipid | UGCG, UGGT1, MAN1B1 | ELANE 1695/4885ABCB1 4864/4885AKR1C3 357/4885 |
| US-20100280231-A1 | WHITENING AGENT COMPRISING EQUOL OR ITS SACCHARIDE DERIVATIVE AS AN EFFECTIVE INGREDIENT | ENO1, GALE, UGGT1 | ELANE 104/4885ABCB1 4262/4885AKR1C3 359/4885 |
| US-20020006414-A1 | EXTERNAL COMPOSITION FOR SKIN COMPRISING SPHINGOGLYCOLIPID | UGCG, MAN2A1, GALK1 | ELANE 604/4885ABCB1 4866/4885AKR1C3 382/4885 |
| US-12221495-B2 | Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide | TSLP, NPR1, VIP | ELANE 2286/4885ABCB1 3903/4885AKR1C3 3299/4885 |
| US-12065512-B2 | Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide | TSLP, NPR1, VIP | ELANE 2286/4885ABCB1 3903/4885AKR1C3 3299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.